Hepatitis C virus and pulmonary fibrosis;Virus dell'epatite C e fibrosi polmonare

Recenti Progressi in Medicina

Volumn 93, Issue 5, 2002, Pages 322-326

  Manganelli, Paolo ^a   Salaffi, Fausto ^b   Pesci, Alberto ^a  

^a Azienda Ospedaliera Universitaria   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Bronchoalveolar lavage; Hepatitis C virus; Idiopathic pulmonary fibrosis; Interferon

Indexed keywords

HEPATITIS C; HUMAN; LUNG FIBROSIS; REVIEW; VIROLOGY;

HEPATITIS C, CHRONIC; HUMANS; PULMONARY FIBROSIS;

EID: 0036584204     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Crystal RG, Fulmer JD, Roberts WC, Moss ML, Line BR, Reynolds HY. Idiopathic pulmonary fibrosis. Clinical, histologic, radiograpnic, scintigrafic, and biochemical aspects. Ann Intern Med 1976; 85: 769-88.
2. Egan JJ, Woodcook AA, Stewart JP. Viruses and idiopathic pulmonary fibrosis. Eur Respir J 1997; 10: 1433-7.
3. Gumber SC. Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepathic manifestations. Ann Intern Med 1995; 123: 615-20.
4. Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999; 42: 2204-12.
5. Ferri C, Zignego AL. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr Opin Rheumatol 2000; 12: 53-60.
6. Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K, Horiuchi T, et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1992; 146: 266-8.
7. Meliconi R, Andreone P, Fasano L, Galli S, Pacilli A, Miniero R, et al. Incidence Df hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax 1996; 51: 315-7.
8. Weidensaul D, Imam T, Holyst M-M. King PD, McMurray RM. Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995; 38: 437-9.
9. Ferri C, La Civita L, Fazzi P, Pasero G. Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection. Arthritis Rheum 1996; 39: 1074-5.
10. Ferri C, La Civita L, Fazzi P, Zolfanelli S, Bombardini F, Begliuomini E, et al. Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol 1997; 36: 360-5.
11. Irving WL, Day S, Johnston IDA. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am Rev Respir Dis 1993; 148: 1683-4.
12. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, et al. Prevalence of chronic liver disease in the general population of Northern Italy: the Dionysos study. Hepatology 1994; 20: 1442-9.
13. Turner-Warwick M, Doniach D. Auto-antibody study in interstitial pulmonary fibrosis. Br Med J 1965; 1: 886-91.
14. Kubo K, Yamaguchi S, Fujimoto K, Hanaoka M, Hayasaka M, Honda T, et al. Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection. Thorax 1996; 51: 312-4.
15. Yamaguchi S, Kubo K, Fujimoto K, Honda T, Sekiguchi M, Sodeyama T. Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha. Thorax 1997; 52: 33-7.
16. Manganelli P, Salaffi F, Subiaco S, Carotti M, Cervini C, Consigli G, et al. Bronchoalveolar lavage in mixed cryoglobulinaemia associated with hepatitis C virus. Br J Rheumatol 1996; 35: 978-82.
17. Bertorelli G, Pesci A, Manganelli P, Schettino G, Olivieri D. Subclinical pulmonary involvement in essential mixed cryoglobulinemia assessed by bronchoalveolar lavage. Chest 1991; 140: 1478-9.
18. Salaffi F, Manganelli P, Carotti M, Subiaco S, Cervini C. Mixed cryoglobulinemia: effect of alpha-interferon on subclinical lymphocyte alveolitis. Clin Exp Rheumatol 1996; 14: 219-20.
19. Keeffe EB, Holliger FB. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group. Hepatology 1997; 26 (3 Suppl 1): 101S-107S.
20. Tilg H. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 1997; 112: 1017-21.
21. Kamisako T, Adachi Y, Chihara J, Yamamoto T. Interstitial pneumonitis and interferon-alfa. Br Med J 1993; 306: 896.
22. Moriya K, Yasuda K, Koike K, Ichinose Y, Yotsuyanagi H, Kurokawa K, et al. Induction of interstitial pneumonitis during interferon treatment for chronic hepatitis C. J Gastroenterol 1994; 29: 514-7.
23. Chin K, Tabata C, Satake N, Nagai S, Moriyasu F, Kuno K. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C. Chest 1994; 105: 939-41.
24. Ishizaki T, Sasaki F, Ameshima S, Shiozaki K, Takahashi H, Abe Y, et al. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. Eur Respir J 1996; 9: 2691-6.
25. Ogata K, Koga T, Yagawa K. Interferon-related bronchiolitis obliterans organizing pneumonitis. Chest 1994; 106: 612-3.
26. Sarrecchia C, Niutta P, Testore GP, Sordillo P, Proietti F, Andreoni M. Fibrosi polmonare interstiziale in corso di epatite cronica da HCV in trattamento con interferone. Rec Prog Med 2001; 92: 336-9.